Dermatol. praxi. 2025;19(4):142-146 | DOI: 10.36290/der.2025.026

Why is scabies still among us (or even among you)?

MUDr. Kateřina Fabiánová, Ph.D.
Oddělení epidemiologie infekčních nemocí, Státní zdravotní ústav v Praze

Scabies is widespread across the world and affects all age groups. Cases of scabies may occur sporadically or in clusters, even leading to epidemics, especially in schools, hospitals, various types of residential care facilities, hostels, and prisons. Staff members of these institutions, particularly those providing nursing or caregiving services, are also at increased risk of infection. Family members of clients and staff are likewise more vulnerable. According to the 2017 European recommendation, basic scabies therapy includes the application of 5% permethrin cream, or oral administration of ivermectin, or the use of 25% benzyl benzoate lotion. Alternatively, 0,5% aqueous malathion cream, 1% ivermectin lotion, or 6-33% sulphur cream, ointment, or lotion may be applied. The aim of this article is to summarize the basic facts, highlight the current situation, and stimulate discussion on the therapeutic options for scabies in the Czech Republic.

Keywords: scabies, Sarcoptes scabiei, permethrin, ivermectin.

Accepted: December 3, 2025; Published: December 16, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fabiánová K. Why is scabies still among us (or even among you)? Dermatol. praxi. 2025;19(4):142-146. doi: 10.36290/der.2025.026.
Download citation

References

  1. Roncalli RA. The history of scabies in veterinary and human medicine from biblical to modern times. Vet Parasitol. 1987 Jul;25(2):193-8. Go to original source... Go to PubMed...
  2. Arlian LG, Runyan RA, Achar S, Estes SA: Survival and infectivity of sarcoptes scabiei var. canis and var. hominis. J Am Acad Dermatol. 1984;11(2 Pt 1):210-5. Go to original source... Go to PubMed...
  3. Arlian LG, Morgan MS. A review of Sarcoptes scabiei: past, present and future. Parasit Vectors. 2017 Jun 20;10(1):297. Go to original source... Go to PubMed...
  4. Sunderkötter C, Wohlrab J, Hamm H. Scabies: Epidemiology, Diagnosis, and Treatment. Dtsch Arztebl Int. 2021 Oct 15;118(41):695-704. Go to original source... Go to PubMed...
  5. Lee SK, Kim JH, Kim MS, et al. Risk factors for scabies treatment resistance: a retrospective cohort study. J Eur Acad Dermatol Venereol. 2022 Jan;36(1):126-132. Go to original source... Go to PubMed...
  6. Beneš J a kol. Infekční lékařství. Praha: Galén; 2009.
  7. Heymann DL. Control of communicable diseases manual. 21th edition. Washington: American Public Health Association; 2022.
  8. Thompson MJ, Engelman D, Gholam K, et al. Systematic review of the diagnosis of scabies in therapeutic trials. Clin Exp Dermatol. 2017 July 1;42(5):481-87. Go to original source... Go to PubMed...
  9. Siddig EE, Hay R. Laboratory-based diagnosis of scabies: a review of the current status. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2022 Jan;116(1):4-9. Go to original source... Go to PubMed...
  10. Engelman D, Yoshizumi J, Hay RJ, et al. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. Br J Dermatol. 2020 Nov;183(5):808-20. Go to original source... Go to PubMed...
  11. Dermanet.cz. Svrab (scabies). [Internet]. [cited 2025 Aug 28] Available from: https://www.dermanet.cz/cs/kozni-choroby/abeceda-koznich-nemoci/svrab-(scabies)__s589x7311.html
  12. Veraldi S, Schianchi R, Silvio M, et al. Pseudoresistance to permethrin in scabies. J Infect Dev Ctries. 2023 May 31;17(5):713-15. Go to original source... Go to PubMed...
  13. Salavastru CM, Chosidow O, Boffa MJ, et al. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1248-53. Go to original source...
  14. British Association of Dermatologists. British Society for Pediatric and Adolescent Dermatology. Management of scabies in UK. Expert consensus guidance October 2023. [Internet]. [cited 2025 Aug 28] Available from: https://cdn.bad.org.uk/uploads/2023/10/Scabies-guidance-OCT-2023.pdf
  15. Sunderkötter C, Wohlrab J, Hamm H. Scabies: Epidemiology, Diagnosis, and Treatment. Dtsch Arztebl Int. 2021;118(41):695-704. Go to original source...
  16. Mbuagbaw L, Sadeghirad B, Morgan RL, et al. Failure of scabies treatment: a systematic review and meta-analysis. Br J Dermatol. 2024 Jan 23;190(2):163-173. Go to original source... Go to PubMed...
  17. Fabiánová K, Košťálová J, Kalinová M, et al. Svrab a současná epidemiologická situace ve výskytu svrabu v České republice. Zprávy CEM. Praha: SZÚ. 2023;32(2): 84-91.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.